These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. Mineo JR, McLeod R, Mack D, Smith J, Khan IA, Ely KH, Kasper LH. J Immunol; 1993 May 01; 150(9):3951-64. PubMed ID: 7682587 [Abstract] [Full Text] [Related]
7. Detection and characterization of membrane antigens of Toxoplasma gondii. Handman E, Goding JW, Remington JS. J Immunol; 1980 Jun 01; 124(6):2578-83. PubMed ID: 7373040 [Abstract] [Full Text] [Related]
8. Antigenic similarity between Hammondia hammondi and Toxoplasma gondii tachyzoites. Riahi H, Bouteille B, Darde ML. J Parasitol; 1998 Jun 01; 84(3):651-3. PubMed ID: 9645881 [Abstract] [Full Text] [Related]
9. [Production and characterization of a panel of monoclonal antibodies to Toxoplasma gondii antigens]. Poryvaeva VA, Aborneva IV, Bormotov NI, Gladkova SE, Reshetnikov SS, Kuvshinova IN, Rukavishnikov MIu, Dedkova LM, Belanov EF. Mol Gen Mikrobiol Virusol; 2003 Jun 01; (4):20-4. PubMed ID: 14664158 [Abstract] [Full Text] [Related]
10. Construction and characterization of recombinant single-chain variable fragment antibodies against Toxoplasma gondii MIC2 protein. Hoe LN, Wan KL, Nathan S. Parasitology; 2005 Dec 01; 131(Pt 6):759-68. PubMed ID: 16336729 [Abstract] [Full Text] [Related]
11. Determination of the specificities of monoclonal and polyclonal antibodies to Neospora, Toxoplasma and Cryptosporidium by fluorescent antibody test (FAT). Latif BM, Jakubek EB. Trop Biomed; 2008 Dec 01; 25(3):225-31. PubMed ID: 19287361 [Abstract] [Full Text] [Related]
12. [Toxoplasma gondii: the characterization of an anti-P30 monoclonal antibody]. Fachado A, Fernández N, Hernández E, Fonseca L. Rev Cubana Med Trop; 1996 Dec 01; 48(3):178-83. PubMed ID: 9805047 [Abstract] [Full Text] [Related]
13. Toxoplasma gondii: stable complementation of sag1 (p30) mutants using SAG1 transfection and fluorescence-activated cell sorting. Kim K, Boothroyd JC. Exp Parasitol; 1995 Feb 01; 80(1):46-53. PubMed ID: 7821410 [Abstract] [Full Text] [Related]
14. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris. Lau YL, Fong MY. Exp Parasitol; 2008 Jul 01; 119(3):373-8. PubMed ID: 18457835 [Abstract] [Full Text] [Related]
16. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. Graille M, Stura EA, Bossus M, Muller BH, Letourneur O, Battail-Poirot N, Sibaï G, Gauthier M, Rolland D, Le Du MH, Ducancel F. J Mol Biol; 2005 Nov 25; 354(2):447-58. PubMed ID: 16242717 [Abstract] [Full Text] [Related]
18. The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii. Pfefferkorn ER, Pfefferkorn LC. J Parasitol; 1978 Jun 25; 64(3):486-92. PubMed ID: 207846 [Abstract] [Full Text] [Related]
19. [Inhibition of invasion and multiplication of Toxoplasma gondii in human colonic epithelial cells by a monoclonal antibody against protein SAG2]. Osorio JC, Sánchez RM, Iraola RC, Pérez JS. Rev Cubana Med Trop; 2001 Jun 25; 53(3):161-9. PubMed ID: 15846919 [Abstract] [Full Text] [Related]